Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hidefumi Amisaki"'
Publikováno v:
Journal of Neuroendovascular Therapy. 17:97-100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d2b20b169811e2057f4c85a42f675d5
https://doi.org/10.5797/jnet.cr.2022-0070
https://doi.org/10.5797/jnet.cr.2022-0070
Autor:
Tsuyoshi Shimizu, Makoto Sakamoto, Hidefumi Amisaki, Yuhei Kuwamoto, Sadao Nakajima, Koichi Torihashi, Tetsuji Uno, Atsushi Kambe, Masamichi Kurosaki
Publikováno v:
Journal of Neuroendovascular Therapy. 16:413-418
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c647f56255b696bc808890ffb0e77543
https://doi.org/10.5797/jnet.cr.2021-0092
https://doi.org/10.5797/jnet.cr.2021-0092
Autor:
Tsuyoshi Shimizu, Hirotaka Inagaki, Atsushi Kambe, Masamichi Kurosaki, Hidefumi Amisaki, Makoto Sakamoto, Satoshi Kuwamoto
Publikováno v:
Neuropathology. 41:315-323
Intracranial myxoid mesenchymal tumor (IMMT) is a recently described, extremely rare group of neoplasms characterized by fusions between the female-expressed transcript (FET) family genes and the cAMP response element-binding protein (CREB) family ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::910a4430f776b8b716bdbf32fbdc2549
https://doi.org/10.1111/neup.12740
https://doi.org/10.1111/neup.12740
Autor:
Hidefumi Amisaki, Atsushi Kambe, Uno Tetsuji, Makoto Sakamoto, Atsushi Yamasaki, Masamichi Kurosaki
Publikováno v:
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58f33d6f94b90f81a95a8b5dfe23afc4
https://pubmed.ncbi.nlm.nih.gov/35051981
https://pubmed.ncbi.nlm.nih.gov/35051981
Autor:
Tsuyoshi Shimizu, Yuhei Kuwamoto, Koichi Torihashi, Masamichi Kurosaki, Atsushi Kambe, Sadao Nakajima, Makoto Sakamoto, Tetsuji Uno, Hidefumi Amisaki
Publikováno v:
Neuro-oncology Advances
Background and purpose: Since the introduction of HD-MTX, cognitive symptoms after irradiation have become a problem mainly in elderly patients. In this study, we evaluated the treatment outcomes of over 70 years old PCNSL patients after HD-MTX intro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e048af5f0857002b172ac49e054c40fb
http://europepmc.org/articles/PMC7699090
http://europepmc.org/articles/PMC7699090